Total Clarity Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Total Clarity Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,500	Closed	-$89K	–	433
2021 Q1	$89K	Buy	+1,500	New	+$90.5K	0.05%	257
2020 Q1	–	Sell	-1,500	Closed	-$80K	–	328
2019 Q4	$80K	Buy	+1,500	New	+$73.9K	0.06%	206

Other funds holding IHE

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Total Clarity Wealth Management's IHE Position: Q2 2021 in Review

Total Clarity Wealth Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2021, closing a stake of 1,500 shares — an estimated $89K sold.

Total Clarity Wealth Management first reported a position in IHE in Q4 2019 and held it in 2 quarters. The position peaked at $89K in Q1 2021. 101 funds tracked by Wall St. Rank hold IHE as of Q2 2021.

Total Clarity Wealth Management reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
Total Clarity Wealth Management sold 1,500 iShares US Pharmaceuticals ETF shares in Q2 2021, an estimated $89K.
Total Clarity Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2019 and held it in 2 quarters.
Total Clarity Wealth Management's iShares US Pharmaceuticals ETF position peaked at $89K in Q1 2021.
101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2021.

Based on Total Clarity Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.